MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
To evaluate the safety and efficacy of MT10109L for the treatment of lateral canthal lines (LCL) with or without concurrent treatment of glabellar lines (GL) in participants with moderate to severe LCL and GL.
Epistemonikos ID: 3bce9c703c7e87e3edf5244989dee00e8ff0b8c3
First added on: May 21, 2024